Year Founded
1992
Ownership
Public
Employees
~5000
Stage
Commercial
Modalities
Medical devicesSmall molecule

Angiotech General Information

Lead product is paclitaxel-eluting coronary stent, implanted in over 1 million patients worldwide. Company focuses on drug-coated medical devices and biomaterials.

Contact Information

Website
Primary Industry
Medical Devices
Corporate Office
Vancouver, British Columbia
Canada

Drug Pipeline

paclitaxel
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Angiotech's pipeline data

Book a demo

Key Partnerships

Boston Scientific, Cook Incorporated

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Angiotech Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Angiotech's complete valuation and funding history, request access »

Angiotech Investors

Vivo Capital LLC
Investor Type: Venture Capital
Holding: Minority
ZQ Capital Limited
Investor Type: Venture Capital
Holding: Minority
GSO Capital Partners LP
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 12 investors. Get the full list »